# Gemcitabine/Capecitabine/ZD6474 in Advanced Solid Tumors

> **NCT00551096** · PHASE1 · COMPLETED · sponsor: **University of Colorado, Denver** · enrollment: 23 (actual)

## Conditions studied

- Malignant Solid Tumour
- Biliary Cancer
- Pancreatic Cancer

## Interventions

- **DRUG:** Gemcitabine
- **DRUG:** Capecitabine
- **DRUG:** ZD6474

## Key facts

- **NCT ID:** NCT00551096
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2013-12-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00551096

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00551096, "Gemcitabine/Capecitabine/ZD6474 in Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00551096. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*